WP
GSK icon

WealthShield Partners’s GSK GSK Stock Holding History

WealthShield Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,566
Closed -$177K – 444
2021
Q2 		$177K Hold
3,566
– – 0.03% 278
2021
Q1 		$159K Buy
+3,566
New +$162K 0.03% 279
2020
Q1 		– Sell
-5,507
Closed -$323K – 289
2019
Q4 		$323K Sell
5,507
-1,345
-20% -$74.8K 0.16% 132
2019
Q3 		$366K Buy
+6,852
New +$352K 0.19% 115

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WealthShield Partners's GSK Position: Q3 2021 in Review

WealthShield Partners sold out of GSK (GSK) in Q3 2021, closing a stake of 3,566 shares — an estimated $177K sold.

WealthShield Partners first reported a position in GSK in Q3 2019 and held it in 4 quarters. The position peaked at $366K in Q3 2019. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • WealthShield Partners reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
  • WealthShield Partners sold 3,566 GSK shares in Q3 2021, an estimated $177K.
  • WealthShield Partners first reported a position in GSK in Q3 2019 and held it in 4 quarters.
  • WealthShield Partners's GSK position peaked at $366K in Q3 2019.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.